|
SP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.723700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.861270E-03 |
| Normal-vs-Stage2 |
2.502600E-01 |
| Normal-vs-Stage3 |
4.254800E-01 |
| Normal-vs-Stage4 |
8.251200E-01 |
| Stage1-vs-Stage2 |
5.198400E-01 |
| Stage1-vs-Stage3 |
6.208200E-02 |
| Stage1-vs-Stage4 |
2.341900E-03 |
| Stage2-vs-Stage3 |
5.347400E-01 |
| Stage2-vs-Stage4 |
2.113600E-01 |
| Stage3-vs-Stage4 |
3.470400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.183760E-02 |
| Normal-vs-AfricanAmerican |
3.515400E-01 |
| Normal-vs-Asian |
1.779220E-01 |
| Caucasian-vs-AfricanAmerican |
1.361730E-02 |
| Caucasian-vs-Asian |
3.915800E-01 |
| AfricanAmerican-vs-Asian |
5.567600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.825900E-02 |
| Normal-vs-Female |
1.319690E-02 |
| Male-vs-Female |
2.190600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.484800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.680180E-02 |
| Normal-vs-Age(61-80Yrs) |
9.415900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.292400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.925600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.316800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.550800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.699400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.750000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.902800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.067600E-02 |
| Normal-vs-Grade 2 |
5.832600E-04 |
| Normal-vs-Grade 3 |
2.494000E-01 |
| Normal-vs-Grade 4 |
3.256000E-01 |
| Grade 1-vs-Grade 2 |
7.572200E-01 |
| Grade 1-vs-Grade 3 |
1.457020E-01 |
| Grade 1-vs-Grade 4 |
2.120400E-02 |
| Grade 2-vs-Grade 3 |
6.423700E-03 |
| Grade 2-vs-Grade 4 |
9.73840000000337E-05 |
| Grade 3-vs-Grade 4 |
4.236300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.65220000003519E-06 |
| Normal-vs-ccB subtype |
5.539600E-01 |
| ccA subtype-vs-ccB subtype |
7.89110000000148E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.547900E-02 |
| Normal-vs-N1 |
7.952400E-01 |
| N0-vs-N1 |
6.425200E-01 |
|
|
